retatrutide triple agonist glp-1 gip glucagon #retatrutide is a novel peptide at the receptor, receptor, and receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter https://t.co/duYwW0EcmF Retatrutide – Efficacy in research,

The set is gentle enough for continuous use to maintain healthy and radiant skin

They have become intentional moments of self-care, reminders to slow down, be present, and honour myself

Justin Yovino notes, The best compliment we receive is when patients say their friends and family notice something different but cant quite put their finger on what changed

This study aimed to quantify temporal trends in GLP-1 RA initiation rates specifically for weight management among eligible adults without diabetes within a large Polish private healthcare network, examining uptake patterns and estimating the national burden of the unmet need in this challenging financial landscape

The 10 mg/day arm showed a smaller reduction than the 1 mg group, confirming the absence of a dose-dependent response above the threshold range